ImpriMed (Series A)
Funding Details
Awarder
Inbox
Date Award
December 19, 2023
Vertical
Precision Medicine
Funding URL
View Funding Page
Funding Amount
$23,000,000
Company Info
Founding Year
2017
Traction
Technology deployed in over 40 U.S. states; 15,000+ canine and feline blood cancer tests performed.
Founders
Sungwon Lim
Market
Oncology
Location
Palo Alto, California, USA
Coinvestors
Byucksan, HRZ Han River Partners, Ignite Innovation, KDB Silicon Valley, Murex Partners, Samyang Chemical Group, SBVASK Telecom Ventures
Company Description

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Precision Medicine DealsView Funding Announcement